Effect of Inspiratory Muscle Training During PR on Dyspnoea and Exercise Tolerance in Chronic Obstructive (COPD)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 34
- Locations
- 2
- Primary Endpoint
- Inspiratory muscle strength
Study Overview
Brief Summary
Chronic obstructive pulmonary disease is a respiratory disease that results in progressive airflow limitation and respiratory distress.
The benefit of inspiratory muscle training (IMT) combined with a pulmonary rehabilitation programme is uncertain. The investigators aimed to demonstrate that, in patients with obstructive pulmonary disease, IMT performed during a PRP is associated with an improvement of dyspnoea and exercise tolerance.
Detailed Description
The purpose of this study is to evaluate the effect of the inspiratory muscle training (with incremental load every two weeks in two months) performed during pulmonary rehabilitation on dyspnoea, 6 minutes walk test and quality of life using the St George's respiratory questionnaire (SGRQ) in COPD patients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Care Provider)
Eligibility Criteria
- Ages
- 45 Years to 75 Years (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Were COPD diagnosed by pulmonary function testing
- •Clinically stable
- •Abscence of other obstructive diseases
- •Signed written consert
Exclusion Criteria
- •Were previous pneumonectomy or lobectomy in the past 6 months
- •spontaneous risk of pneumothorax or rib fracture
- •Incapacity to follow a standard rehabilitation programme (locomotor deficits, acute cardiac failure and acute exacerbation of COPD at the beginning of the programme)
- •The absence of written informed consent.
Outcomes
Primary Outcomes
Inspiratory muscle strength
Time Frame: Baseline, After 2 months
The inspiratory muscle strength were measured by maximal inspiratory pressure test
Dyspnoea
Time Frame: Baseline, After 2 months
The dyspnoea were measured before and after the 6 minutes walk test
Secondary Outcomes
No secondary outcomes reported
Investigators
Bilel Tounsi
PhD
Faculty of Medicine, Sousse